Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 3

Behavior and neuropsychiatric manifestations in Angelman syndrome

Authors Karine Pelc, Guy Cheron, Bernard Dan

Published 6 June 2008 Volume 2008:4(3) Pages 577—584


Karine Pelc1, Guy Cheron2, Bernard Dan1,2

1Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium; 2Laboratory of Neurophysiology and Movement Biomechanics, Université Libre de Bruxelles (ULB), Brussels, Belgium

Abstract: Angelman syndrome has been suggested as a disease model of neurogenetic developmental condition with a specific behavioral phenotype. It is due to lack of expression of the UBE3A gene, an imprinted gene located on chromosome 15q. Here we review the main features of this phenotype, characterized by happy demeanor with prominent smiling, poorly specific laughing and general exuberance, associated with hypermotor behavior, stereotypies, and reduced behavioral adaptive skills despite proactive social contact. All these phenotypic characteristics are currently difficult to quantify and have been subject to some differences in interpretation. For example, prevalence of autistic disorder is still debated. Many of these features may occur in other syndromic or nonsyndromic forms of severe intellectual disability, but their combination, with particularly prominent laughter and smiling may be specific of Angelman syndrome. Management of problematic behaviors is primarily based on behavioral approaches, though psychoactive medication (eg, neuroleptics or antidepressants) may be required.

Keywords: Angelman syndrome, UBE3A, chromosome 15, behavioral phenotypes, autism, neurogenetics

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Physicochemical properties, cytotoxicity, and antimicrobial activity of sulphated zirconia nanoparticles

Mftah A, Alhassan FH, Al-Qubaisi MS, El Zowalaty ME, Webster TJ, Sh-eldin M, Rasedee A, Taufiq-Yap YH, Rashid SS

International Journal of Nanomedicine 2015, 10:765-774

Published Date: 19 January 2015

The long-term survival of a thymic carcinoma patient treated with S-1: a case report and literature review

Tanaka H, Morimoto T, Taima K, Tanaka Y, Nakamura K, Hayashi A, Kurose A, Okumura K, Takanashi S

OncoTargets and Therapy 2014, 7:87-90

Published Date: 27 December 2013

Synthesis, characterization, and antimicrobial properties of copper nanoparticles

Usman MS, El Zowalaty ME, Shameli K, Zainuddin N, Salama M, Ibrahim NA

International Journal of Nanomedicine 2013, 8:4467-4479

Published Date: 21 November 2013

Biodistribution, kinetics, and biological fate of SPION microbubbles in the rat

Barrefelt A, Saghafian M, Kuiper R, Ye F, Egri G, Klickermann M, Brismar TB, Aspelin P, Muhammed M, Dähne L, Hassan M

International Journal of Nanomedicine 2013, 8:3241-3254

Published Date: 26 August 2013

Controlled gentamicin release from multi-layered electrospun nanofibrous structures of various thicknesses

Sirc J, Kubinova S, Hobzova R, Stranska D, Kozlik P, Bosakova Z, Marekova D, Holan V, Sykova E, Michalek J

International Journal of Nanomedicine 2012, 7:5315-5325

Published Date: 8 October 2012

Pharmacotherapy of panic disorder

Charles B Pull, Cristian Damsa

Neuropsychiatric Disease and Treatment 2008, 4:779-795

Published Date: 8 August 2008

Not Geropharmacotherapy 101

Albert J Finestone, Michael R Jacobs, John A Cacciamani

Clinical Interventions in Aging 2007, 2:715-718

Published Date: 15 January 2008

Zolpidem modified-release in insomnia

Cynthia Kirkwood, Jason Neill, Ericka Breden

Neuropsychiatric Disease and Treatment 2007, 3:521-526

Published Date: 15 November 2007